Transforming growth factor β type I receptor kinase mutant associated with metastatic breast cancer

Cancer Research

Volumn 58, Issue 21, 1998, Pages 4805-4810

  Chen, Taiping ^a   Carter, Darryl ^a   Garrigue Antar, Laure ^a,b   Reiss, Michael ^a  

^a YALE CANCER CENTER   (United States)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; AMINO ACID; CYTOSINE; MUTANT PROTEIN; NUCLEIC ACID BASE; PROTEIN KINASE; SERINE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TYROSINE;

AMINO ACID SUBSTITUTION; ARTICLE; BREAST CARCINOMA; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MUTANT; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; RECEPTOR GENE; STRUCTURE ANALYSIS;

AMINO ACID SEQUENCE; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA;

EID: 0032213514     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Hosobuchi, M., and Stampfer, M. R. Effects of transforming growth factor β on growth of human mammary epithelial cells in culture. In Vitro Cell. Dev. Biol., 25: 705-713, 1989.
2. Pierce, D. F., Jr., Johnson, M. D., Matsui, Y., Robinson, S. D., Gold, L. I., Purchio, A. F., Daniel, C. W., Hogan, B. L., and Moses, H. L. Inhibition of mammary duct development but not alveolar outgrowth during pregnancy in transgenic mice expressing active TGF-β1. Genes Dev., 7: 2308-2317, 1993.
3. Jhappan, C., Geiser, A. G., Kordon, E. C., Bagheri, D., Hennighausen, A. B., Roberts, A. B., Smith, G. H., and Merlino, G. Targeting expression of a transforming growth factor β1 transgene to the pregnant mammary gland inhibits alveolar development and lactation. EMBO J., 12: 1835-1845, 1993.
4. Strange, R., Li, F., Saurer, S., Burkhardt, A., and Friis, R. R. Apoptotic cell death and tissue remodelling during mouse mammary gland involution. Development, 115: 49-58, 1992.
5. Reiss, M., and Barcellos-Hoff, M. H. The role of transforming growth factor β in breast cancer: a working hypothesis. Breast Cancer Res. Treat., 45: 81-95, 1997.
6. Pierce, D. F., Jr., Gorska, A. E., Chytil, A., Meise, K. S., Page, D. L., Coffey, R. J., Jr., and Moses, H. L. Mammary tumor suppression by transforming growth factor β1 transgene expression. Proc. Natl. Acad. Sci. USA, 92: 4254-4258, 1995.
7. Tang, B., B̈ttinger, E. P., Jakowlew, S. B., Bagnall, K. M., Mariano, J., Anver, M. R., Letterio, J. J., and Wakefield, L. M. Transforming growth factor β1 is a new form of tumor suppressor with true haploid insufficiency. Nat. Med., 4: 802-807, 1998.
8. Wang, X-J., Greenhalgh, D. A., Bickenbach, J. R., Jiang, A., Bundman, D. S., Krieg, T., Derynck, R., and Roop, D. R. Expression of a dominant-negative type II transforming growth factor β (TGFβ) receptor in the epidermis of transgenic mice blocks TGFβ-mediated growth inhibition. Proc. Natl. Acad. Sci. USA, 94: 2386-2391, 1997.
9. Böttinger, E. P., Jakubczak, J. L., Haines, D. C., Bagnall, K., and Wakefield, L. M. Transgenic mice overexpressing a dominant-negative mutant type II transforming growth factor β receptor show enhanced tumorigenesis in the mammary gland and lung in response to the carcinogen 7,12-dimethylbenz-[a]-anthracene. Cancer Res., 57: 5564-5570, 1997.
10. Heldin, C-H., Miyazono, K., and ten Dijke, P. TGFβ signaling from cell membrane to nucleus through SMAD proteins. Nature (Lond.), 390: 465-471, 1997.
11. Lin, H. Y., Wang, X-F., Ng-Eaton, E., Weinberg, R. A., and Lodish, H. F. Expression cloning of the TGFβ type II receptor, a functional transmembrane serine/threonine kinase. Cell, 68: 775-785, 1992.
12. Kalkhoven, E., Roelen, B. A. J., de Winter, J. P., Mummery, C. L., van den Eijnden-van Raaij, A. J. M., van der Saag, P. T., and van der Burg, B. Resistance to transforming growth factor β and activin due to reduced receptor expression in human breast tumor cell lines. Cell Growth Diff., 6: 1151-1156, 1995.
13. Schutte, M., Hruban, R. H., Hedrick, L., Cho, K. R., Nadasdy, G. M., Weinstein, C. L., Bova, G. S., Isaacs, W. B., Cairns, P., Nawroz, H., Sidransky, D., Casero, R. A., Jr., Meltzer, P. S., Hahn, S. A., and Kern, S. E. DPC4 gene in various tumor types. Cancer Res., 56: 2527-2530, 1996.
14. de Winter, J. P., Roelen, B. A., ten Dijke, P., van der Burg, B., and van den Eijnden-van Raaij, A. J. DPC4 (SMAD4) mediates transforming growth factor β1 (TGF-β1) induced growth inhibition and transcriptional response in breast tumour cells Oncogene, 14: 1891-1899, 1997.
15. Riggins. G. J., Kinzler, K. W., Vogelstein, B., and Thiagalingam, S. Frequency of Smad gene mutations in human cancers. Cancer Res., 57: 2578-2580, 1997.
16. Eppert, K., Scherer, S. W., Ozcelik, H., Pirone, R., Hoodless, P., Kim, H., Tsui, L-C., Bapat, B., Gallinger, S., Andrulis, I., Thomsen, G. H., Wrana, J. L., and Attisano, L. MADR2 maps to 18q21 and encodes a TGF-β MAD-related protein that is functionally mutated in colorectal carcinoma. Cell, 86: 543-552, 1996.
17. Yokota, T., Matsumoto, S., Yoshimoto, M., Kasumi, F., Akiyama, F., Sakamoto, G., Nakamura, Y., and Emi, M. Mapping of a breast cancer tumor suppressor gene locus to a 4-cM interval on chromosome 18q21. Jpn. J. Cancer Res., 88: 959-964, 1997.
18. Chen, T., Dhingra, K., Sahin, A., Sneige, N., Hortobagyi, G., and Aldaz, C. M. Technical approach for the study of the genetic evolution of breast cancer from paraffin-embedded tissue sections. Breast Cancer Res. Treat., 39: 177-185, 1996.
19. Garrigue-Antar, L., Munoz-Antonia, T., Antonia, S. J., Gesmonde, J., Vellucci, V. F., and Reiss, M. Missense mutations of the transforming growth factor β type II receptor in human head and neck squamous carcinoma cells. Cancer Res., 55: 3982-3987, 1995.
20. Lu, S., Zhang, W., Akiyama, Y., Nomizu, T., and Yuasa, Y. Genomic structure of the transforming growth factor β type II receptor gene and its mutations in hereditary nonpolyposis colorectal cancers. Cancer Res., 56: 4595-4598, 1996.
21. Hongyo, T., Buzard, G. S., Calvert, R. J., and Weghorst, C. M. "Cold SSCP": a simple, rapid and non-radioactive method for optimized single-strand conformation polymorphism analyses. Nucleic Acids Res., 21: 3637-3642, 1993.
22. Franźn, P., ten Dijke, P., Ichijo, H., Yamashita, H., Schulz, P., Heldin, C-H., and Miyazono, K. Cloning of a TGFβ type I receptor that forms a heterodimeric complex with the TGFβ type II receptor. Cell, 75: 681-692, 1993.
23. Wilson, I. A., Niman, H. L., Houghten, R. A., Cherenson, A. R., Connolly, M. L., and Lerner, R. A. The structure of an antigenic determinant in a protein. Cell, 37: 767-778, 1984.
24. De, M., Yan, W., De Jonge, R. R., Garrigue-Antar, L., Vellucci, V. F., and Reiss, M. Functional characterization of transforming growth factor-β type II receptor mutants in human cancer. Cancer Res., 58: 1986-1992, 1998.
25. Feng, X-H., Filvaroff, E. H., and Derynck, R. Transforming growth factor-β (TGFβ)-induced down-regulation of cyclin A expression requires a functional TGFβ receptor complex. J. Biol. Chem., 270: 24237-24245, 1995.
26. Zawel, L., Dai, J. L., Buckhaults, P., Zhou, S., Kinzler, K. W., Vogelstein, B., and Kern, S. E. Human Smad3 and Smad4 are sequence-specific transcription activators. Mol. Cell., 1: 611-617, 1998.
27. Garrigue-Antar, L., Souza, R. F., Vellucci, V. F., Meltzer, S. J., and Reiss, M. Loss of transforming growth factor-β type II receptor gene expression in human esophageal cancer. Lab. Invest., 75: 263-272, 1996.
28. De Jonge, R. R., Garrigue-Antar, L., Vellucci, V. F., and Reiss, M. Frequent inactivation of the transforming growth factor type II receptor in small cell lung carcinoma cells. Oncol. Res., 9: 89-98, 1997.
29. Knaus, P. I., Lindemann, D., DeCoteau, J. F., Perlman, R., Yankelev, H., Hille, M., Kadin, M. E., and Lodish, H. F. A dominant inhibitory mutant of the type II transforming growth factor β receptor in the malignant progression of a cutaneous T-cell lymphoma. Mol. Cell. Biol., 16: 3480-3489, 1996.
30. Wang, D., Song, H., Evans, J. A., Lang, J. C., Schuller, D. E., and Weghorst, C. M. Mutation and downregulation of the transforming growth factor β type II receptor gene in primary squamous cell carcinomas of the head and neck. Carcinogenesis (Lond.)., 18: 2285-2290, 1997.
31. Myeroff, L. L., Parsons, R., Kim, S-J., Hedrick, L., Cho, K. R., Orth, K., Mathis, M., Kinzler, K. W., Lutterbaugh, J., Park, K., Bang, Y-J., Lee, H. Y., Park, J-G., Lynch, H. T., Roberts, A. B., Vogelstein, B., and Markowitz, S. D. A transforming growth factor β type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability. Cancer Res., 55: 5545-5547, 1995.
32. Chen, T., De Vries, E. G. E., Hollema, H., and Reiss, M. Frequent mutations in transforming growth factor-β (TGFβ) receptor I (TβR-I) and II (TβR-II) genes in cervical carcinoma. Proc. Am. Assoc. Cancer Res., 39: 282, 1998.
33. Pasche, B., Luo, Y., Rao, P. H., Nimer, S. D., Dmitrovsky, E., Caron, P., Luzzatto, L., Offit, K., Cordon-Cardo, C., Renault, B., Satagopan, J. M., Murty, V. V. V., and Massagué, J. Type I transforming growth factor β maps to 9q22 and exhibits a polymorphism and rare variant within a polyalanine tract. Cancer Res., 58: 2727-2732, 1998.
34. Cailleau, R., Olive, M., and Cruciger, Q. V. Long-term human breast carcinoma cell lines of metastatic origin: preliminary characterization. In Vitro, 14: 911-915, 1978.
35. Portella, G., Cumming, S. A., Liddell, J., Cui, W., Ireland, H., Akhurst, R. J., and Balmain, A. Transforming growth factor β is essential for spindle cell conversion of mouse skin carcinoma in vivo: implications for tumor invasion. Cell Growth Diff., 9: 393-404, 1998.
36. Akiyama, Y., Iwanaga, R., Saitoh, K., Shiba, K., Ushio, K., Ikeda, E., Iwama, T., Nomizu, T., and Yuasa, Y. Transforming growth factor β type II receptor gene mutations in adenomas from hereditary non-polyposis colorectal cancer. Gastroenterology, 112: 33-39, 1997.
37. Grady, W. M., Rajput, A., Myeroff, L., Liu, D. F., Kwon, K., Willis, J., and Markowitz, S. Mutation of the type II transforming growth factor-β receptor is coincident with the transformation of human colon adenomas to malignant carcinomas. Cancer Res., 58: 3101-3104, 1998.
38. Taylor, S. S., Knighton, D. R., Zheng, J., Ten Eyck, L. F., and Sowadski, J. M. Structural framework for the protein kinase family. Annu. Rev. Cell Biol., 8: 429-462, 1992.
39. Hanks, S. K., and Hunter, T. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification. FASEB J., 9: 576-596, 1995.
40. Souchelnytskyi, S., Tamaki, K., Engstrom, U., Wernstedt, C., ten Dijke, P., and Heldin, C. H. Phosphorylation of Ser465 and Ser467 in the C terminus of Smad2 mediates interaction with Smad4 and is required for transforming growth factor β signaling. J. Biol. Chem., 272: 28107-28115, 1997.
41. Lo, R. S. Chen, Y. G., Shi, Y., Pavletich, N. P., and Massagú, J. The L3 loop: a structural motif determining specific interactions between SMAD proteins and TGF-β receptors. EMBO J., 17: 996-1005, 1998.
42. Knighton, D. R., Zheng, J., Ten Eyck, L. F., Xuong, N. H., Taylor, S. S., and Sowadski, J. M. Structure of a peptide inhibitor bound to the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase. Science (Washington DC), 253: 414-420, 1991.
43. Chou, P. Y., and Fasman, G. D. Prediction of the secondary structure of proteins from their amino acid sequence. Adv. Enzymol., 47: 45-148, 1978.
44. Feng, X-H., and Derynck, R. A kinase subdomain of transforming growth factor β (TGF-β) type I receptor determines the TGF-β intracellular signaling specificity. EMBO J., 3912-3923, 1997.
45. Johnson, D. W., Berg, J. N., Baldwin, M. A., Gallione, C. J., Marondel, I., Yoon, S. J., Stenzel, T. T., Speer, M., Pericak-Vance, M. A., Diamond, A., Guttmacher, A. E., Jackson, C. E., Attisano, L., Kucherlapati, R., Porteous, M. E., and Marchuk, D. A. Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat. Genet., 13: 189-195, 1996.
46. Berg, J. N., Gallione, C. J., Stenzel, T. T., Johnson, D. W., Allen, W. P., Schwartz, C. E., Jackson, C. E., Porteous, M. E. M., and Marchuk, D. A. The activin receptor-like kinase 1 gene genomic structure and mutations in hereditary hemorrhagic telangiectasia type 2. Am. J. Hum. Genet., 61: 60-67, 1997.
47. Maichele, A. J., Burwinkel, B., Maire, I., Søvik, O., and Kilimann, M. W. Mutations in the testis/liver isoform of the phosphorylase kinase γ subunit (PHKG2) cause autosomal liver glycogenosis in the gsd rat and in humans. Nat. Genet., 14: 337-340, 1998.